Of interest, prostate-specific membrane antigen (PSMA) radioligand tracers and 18F-fluorocholine also appear to exhibit a lack of enhanced uptake by some sclerotic bone lesions in patients with prostate cancer, based on comparisons with 18F-sodium fluoride [15–17]. This evidence concerns the gene FOLH1 and prostate carcinoma.